Single Vs. Multiple Fraction Non-Inferiority Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligo-Metastases/progression: SIMPLIFY-SABR-COMET Robert Olson , Hadassah Abraham , Curtis Leclerc , Alexander Benny , Sarah Baker , Quinn Matthews , Nick Chng , Alanah Bergman , Benjamin Mou , Emma M. Dunne , Devin Schellenberg , Will Jiang , Elisa Chan , Siavash Atrchian , Shilo Lefresne , Hannah Carolan , Boris Valev , Scott Tyldesley , Andrew Bang , Tanya Berrang , Haley Clark , Fred Hsu , Alexander V. Louie , Andrew Warner , David A. Palma , Doris Howell , Aisling Barry , Laura Dawson , Petra Grendarova , Debra Walker , Rishi Sinha , Jillian Tsai , Houda Bahig , Isabelle Thibault , Rashmi Koul , Sashendra Senthi , Iain Phillips , Derek Grose , Paul Kelly , John Armstrong , Ronan McDermott , Candice Johnstone , Srini Vasan , Noel Aherne , Stephen Harrow , Mitchell Liu BMC Cancer（2024）
Key words
Stereotactic ablative radiotherapy, Oligometastases, Quality of Life, Survival, Cancer, Single Fraction
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
